Graves’ Disease following Interferon Therapy for Chronic Hepatitis C Infection

Authors

Omayma El Shafie, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman
Samir Hussein, Departments of Radiology and Molecular Imaging, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman
Waheed El Awady, Departments of Medicine, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman
Nicholas Woodhouse, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman

Abstract

We describe the first case of Graves’ disease occurring at Sultan Qaboos University Hospital, Oman, in a patient who was under treatment with interferon alfa for HCV infection. INF-α is now being widely used to treat patients with a variety of disorders including infection with hepatitis C virus. Clinical thyroid disease, hypo and hyperthyroidism can occur in up to 15% of patients. We emphasize the need for thyroid function screening before and during therapy to identify patients early in the course of their disease.

Publication Date

3-31-2008

First Page

75

Last Page

77

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Shafie, Omayma El; Hussein, Samir; Awady, Waheed El; and Woodhouse, Nicholas (2008) "Graves’ Disease following Interferon Therapy for Chronic Hepatitis C Infection," Sultan Qaboos University Medical Journal: Vol. 8: 75-77.
DOI: https://doi.org/10.18295/2075-0528.2697